Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New dental implant study tests which surface helps teeth stay put

NCT ID NCT06034171

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested two different surface treatments on dental implants in 50 people who had no teeth in their lower jaw. The implants replace missing tooth roots and support bridges or dentures. Researchers measured how well the implants fused with the bone and how the treatment affected quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
dental implant with either phosphate or hydroxylapatite surface treatment
What this could lead to
If successful, this could show which surface treatment helps implants fuse better with the jawbone, improving long-term stability.
What could go wrong
This is a small, completed study with only 50 participants, so results may not apply to everyone. The implants are for the lower jaw only.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Jun 2019

Finished

Dec 2023

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * complete lack of teeth in the lower jaw * decision of the investigator: the patient is appropriate for implantation, clinical conditions are sufficient (adequate soft tissue and bone conditions and occlusal position;) * the patient's consciousness is clear, understand the planned intervention. * the patient communicates well with the examiner and is able to understand and comply with the requirements of the test plan. * witten informed consent Exclusion Criteria: * Pregnant or lactating women * Women of childbearing potential, unless she uses effective birth control until the completion of the final radiological examination, and for another 4 weeks after that. * A disease (including, but not limited to metabolic, hematological, kidney, liver, lung, neurological, endocrine, cardiac, infectious and gastrointestinal disease), which -in the opinion of the investigator- significantly affects the health of the examined person and/or exposes to an unacceptably high risk the person receiving the implantation treatment. * Malignant disease in the medical history in the preceding 24 months. * Known HIV, hepatitis B or hepatitis C, or any other considered viral infection relevant by the examiner known at the tome of randomization * A medical or psychiatric illness which, in the opinion of the investigator, excludes that the participant adheres to the protocol, or complete the study according to the protocol. * Participation in an other interventional clinical study within 6 months prior to treatment. * Known allergy to the implant or to the invetigational template or any of its components. * Limitation of mouth opening, which make unpossible to complete the procedure, based on the opinion of the investigator * Increased pharyngeal reflex, reduced ability to tolerate intraoral manipulation * Radiotherapy, previous irradiation of the jawbones * INR \> 2.5 * Immunosuppressed patient * previous or current bisphosphonate treatment * Known alcohol or drug abuse * Heavy smoking (≥ 20 cigarettes per day, or another form of smoking, used in an equivalent amount) * Untreated periodontitis * Local infection of the implant in the planned area * Lack of dental hygiene, e.g. not removed radixes, plaque and calculus, or radiologically detectable potential periapical focus (also in asymptomatic case ) * Insufficient or poor oral hygiene * Transient infectious state, with or without fever

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dental implant are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • SmileDent Kft.

    Szeged, 6724, Hungary

More trials for these conditions

Other studies related to the condition(s) this trial covers.